Intravenous clinical trials

Explore recruiting intravenous clinical trials.

Recruiting intravenous studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intravenous trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Electrophysiological analysis of Gamma-Hydroxybutyrate-induced sleep in intensive care patients: A Pilot Double-Blind Randomized Controlled Trial.(GAMMA-SLEEP)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Defining the Glucagon Unit: Investigating the Impact on Energy Expenditure and Glucose Level Deviation in healthy volunteers

Latvia

Human Pharmacology (Phase I)- Other EU CTIS Study details

Ventricular water absorption capacity in hydrocephalus

Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Inhaled sedation in the critically ill patient: a multicentre randomised clinical trial

Spain

Therapeutic use (Phase IV) EU CTIS Study details

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy of a Single Intravenous Dose of SGT-003 in Ambulant Males With Duchenne Muscular Dystrophy

Spain, Netherlands, France, Italy, Belgium, Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Thrombolysis with Tenecteplase for Acute Ischemic Stroke in Patients taking Direct Oral Anticoagulants – a multicentre randomised placebo-controlled clinical trial

Germany

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intravenous trials by city

Intravenous in Toronto Intravenous in Vancouver Intravenous in Montreal Intravenous in Calgary Intravenous in Edmonton Intravenous in Ottawa Intravenous in Winnipeg Intravenous in Quebec City Intravenous in Hamilton Intravenous in Kitchener Intravenous in London Intravenous in Halifax Intravenous in New York Intravenous in Los Angeles Intravenous in Chicago Intravenous in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease